Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Penske Automotive Group Q1 Profit Rises - Quick Facts

RELATED NEWS
Trade PAG now with 

Penske Automotive Group Inc. (PAG: Quote) reported that its first-quarter net income attributable to common shareholders was $46.82 million or $0.52 per share, compared to $33.93 million or $0.37 per share in the same quarter last year.

Income from continuing operations attributable to common shareholders increased 37.3% to $50.0 million and related earnings per share increased 41.0% to $0.55 per share. This compares to income from continuing operations attributable to common shareholders of $36.4 million, or $0.39 per share in the same period last year.

First quarter revenue increased by 17.9% to $3.2 billion, driven by an improvement in total retail unit sales of 18.1% and growth in the Company's used-to-new ratio to 0.89 to 1 from 0.78 to 1 in the same period last year.

Analysts polled by Thomson Reuters expected the company to report earnings of $0.47 per share on revenues of $3.12 billion for the quarter. Analysts' estimates typically exclude special items.

Click here to receive FREE breaking news email alerts for Penske Automotive Group Inc. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Proctor and Gamble (PG) has sold two of its soap brands to European consumer products giant Unilever (UN). Cincinnati-based P&G says the sale includes the global Camay brand, the Zest brand outside of North America and its Talisman manufacturing plant in Mexico. The plant employs approximately... Dish Network is no longer carrying Fox News in yet another dispute for the television provider. Fox News, which changed the face of cable news with its ardent advocacy of conservative issues, went dark Sunday, replaced on Dish by The Blaze, Glen Beck's new right-leaning channel. Fox Business channel... Swiss drug maker Roche Holding said a late-stage trial of its breast cancer drug Kadcyla did not provide superior results compared with an existing therapy.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.